1 |
Heizmann P, Eckert M, Ziegler WH. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol. 1983;16(suppl):43S-9S.
DOI
|
2 |
Hohmann N, Kocheise F, Carls A, et al. Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans. Br J Clin Pharmacol. 2015;79(2):278-85.
DOI
|
3 |
Shin KH, Choi MH, Lim KS, et al. Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance. Clin Pharmacol Ther 2013;94(5):601-9.
DOI
|
4 |
Bonate PL, Chapter 4 Variance Models, Weighting, and Transformations, In: San Antonio, Pharmacokinetic-Pharmacodynamic Modeling and Simulation, TX USA: Springer, 2006;126-7
|
5 |
Kim SE, Kim BH, Lee S, et al. Population pharmacokinetics of theophylline in premature Korean infants. Ther Drug Monit. 2013;35(3):338-44.
DOI
|
6 |
Duffull SB, Wright DF, Winter HR. Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint. Br J Clin Pharmacol. 2011;71(6):807-14.
DOI
|
7 |
Zomorodi K, Donner A, Somma J, et al. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology 1998; 89(6):1418-29.
DOI
|
8 |
Jones RD, Chan K, Roulson CJ, et al. Pharmacokinetics of flumazenil and midazolam. Br J Anaesth 1993; 70(3):286-92.
DOI
|
9 |
Maitre PO, Funk B, Crevoisier C, et al. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur J Clin Pharmacol. 1989;37(2):161-6.
DOI
|
10 |
Leucuta SE and Vlase L. Pharmacokinetics and metabolic drug interactions. Curr Clin Pharmacol 2006;1(1):5-20.
DOI
|
11 |
Arendt RM, Greenblatt DJ, Garland WA. Quantitation by gas chromatography of the 1- and 4-hydroxy metabolites of midazolam in human plasma. Pharmacology 1984;29(3):158-64.
DOI
|
12 |
Seo KA, Bae SK, Choi YK, et al. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7. Drug Metab Dispos 2010; 38(11):2007-13.
DOI
|